| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. | Chief Scientific Officer | Common Stock | 815,734 | $8,524,339 | $10.45 | 18 Jun 2021 | Direct |
| Checkmate Pharmaceuticals, Inc. | Chief Scientific Officer | Common Stock | 0 | $10.45 | 28 May 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924321024984-krieg-arthur-m-2021-06-18 | Checkmate Pharmaceuticals, Inc. | 18 Jun 2021 | 1 | +$43,633 | 4 | Chief Scientific Officer | 21 Jun 2021, 16:26 |
| /report/000089924321024427-krieg-arthur-m-2021-06-16 | Checkmate Pharmaceuticals, Inc. | 16 Jun 2021 | 1 | +$22,112 | 4 | Chief Scientific Officer | 17 Jun 2021, 16:33 |
| /report/000089924321021392-krieg-arthur-m-2021-05-28 | Checkmate Pharmaceuticals, Inc. | 28 May 2021 | 3 | $0 | 4 | Chief Scientific Officer | 01 Jun 2021, 18:44 |
| /report/000089924321019922-krieg-arthur-m-2021-05-18 | Checkmate Pharmaceuticals, Inc. | 18 May 2021 | 1 | +$174,257 | 4 | Chief Scientific Officer | 19 May 2021, 16:15 |